Summary
• Aimei Health Technology Co., Ltd (AFJK) stock fell 6.3% to $25.25 in after-hours trading.
• Trading volume is significantly below averages, with a current volume of 445 compared to a 10-day average of 1.1 million shares.
• Year-to-date, AFJK stock is up 151.96%, but recent weekly performance shows a decline of 69.54%.
Aimei Health Technology Co., Ltd (AFJK) saw its stock price drop to $25.25 in after-hours trading, marking a decrease of 6.3% from its last close of $26.96. The decline comes without a clear catalyst, as market participants evaluate routine trading conditions.
Market and Technical Picture
AFJK’s stock performance has reflected substantial fluctuations over recent periods. The current volume stands at 445, notably below the averages, with a 10-day average volume of approximately 1.1 million shares and a 3-month average of around 138,000 shares. This might suggest lower trading activity compared to past levels.
From a technical standpoint, Aimei Health’s Relative Strength Index (RSI) sits at 52.96, indicating a relatively neutral trading momentum. The company has experienced notable volatility, with a weekly volatility of 237.27% and monthly volatility of 65.01%. The stock is below key simple moving averages (SMA), with a 20-day SMA at 40.39 and a 50-day SMA at 81.87, further highlighting recent struggles.
[chart type=’price’ value=’AFJK’]
Performance Overview
In terms of performance metrics, Aimei Health has seen significant swings in its price. Year-to-date, the stock has surged by 151.96%, reflecting strong performance over the longer term. However, the contrasting quarterly and monthly performances show gains of 138.58% and 130.43%, respectively, while weekly performance indicates a steep decline of 69.54%. The stock is also positioned within a broader context, with its 52-week high and low marked at a considerable $299.41 and -72.53, respectively.
[chart type=’performance’ value=’AFJK’]
Regulatory / SEC Filings
The most recent filing for Aimei Health was a Form 8-K submitted on December 8, 2025. Details on the content of the filing are not available in the current data, and it has not been linked to any prominent movements in the stock price in this session.
With the latest update now reflected in trading, investors will be monitoring how the stock’s volume and momentum develop in the next session.